ANI Pharmaceuticals, Inc.
ANIP
$75.42
-$1.12-1.46%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 78.34M | 40.57M | -10.21M | -21.05M | -18.52M |
| Total Depreciation and Amortization | 91.42M | 91.40M | 84.52M | 75.94M | 67.73M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.59M | 23.80M | 23.72M | 25.48M | 25.99M |
| Change in Net Operating Assets | -7.12M | 14.95M | 41.11M | 369.00K | -11.19M |
| Cash from Operations | 185.23M | 170.72M | 139.14M | 80.74M | 64.02M |
| Capital Expenditure | -13.84M | -14.99M | -13.69M | -14.13M | -16.24M |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 0.00 | 13.51M |
| Cash Acquisitions | -- | -8.20M | -401.28M | -401.28M | -401.28M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.49M | -20.41M | -20.98M | -18.09M | -717.00K |
| Cash from Investing | -34.32M | -43.60M | -435.96M | -433.50M | -404.72M |
| Total Debt Issued | -- | 0.00 | 641.25M | 641.25M | 641.25M |
| Total Debt Repaid | -10.16M | -8.12M | -298.59M | -297.31M | -296.03M |
| Issuance of Common Stock | 13.60M | 15.27M | 6.67M | 6.43M | 6.49M |
| Repurchase of Common Stock | -12.21M | -11.92M | -11.55M | -12.30M | -10.96M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.16M | -1.56M | -1.63M | -1.63M | -1.63M |
| Other Financing Activities | -26.00K | -3.88M | -61.68M | -61.68M | -74.18M |
| Cash from Financing | -9.94M | -10.22M | 274.47M | 274.77M | 264.95M |
| Foreign Exchange rate Adjustments | -233.00K | 725.00K | 74.00K | -767.00K | -470.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 140.73M | 117.63M | -22.28M | -78.76M | -76.23M |